Alan Kerr II, MD, PhD is a hematologist-oncologist and physician scientist at Tampa General Hospital Cancer Institute. With expertise in malignant hematology, Dr. Kerr has a strong background in translational and clinical research, and is actively involved in numerous clinical trials. He is a diplomate of the American Board of Internal Medicine and a member of the American Society of Clinical Oncology and the American Society of Hematology.
Dr. Kerr completed his medical degree at the University of Louisville School of Medicine and holds a PhD in biochemistry and molecular biology from the same institution. He completed his residency in internal medicine at the University of Louisville and a fellowship in hematology and medical oncology at Moffitt Cancer Center University of South Florida. Dr. Kerr's primary clinical interests lie in lymphomas, and he has contributed to several publications, oral presentations, and abstracts in the field of oncology.
Generated from the website